Corrigendum: Fucoidan ameliorates renal injury-related calcium-phosphorus metabolic disorder and bone abnormality in the CKD-MBD model rats by targeting FGF23-Klotho signaling axis

Bu-Hui Liu; Fee-Lan Chong; Can-Can Yuan; Ying-Lu Liu; Hai-Ming Yang; Wen-Wen Wang; Qi-Jun Fang; Wei Wu; Mei-Zi Wang; Yue Tu; Zi-Yue Wan; Yi-Gang Wan; Guo-Wen Wu

doi:10.3389/fphar.2024.1446609

Corrigendum: Fucoidan ameliorates renal injury-related calcium-phosphorus metabolic disorder and bone abnormality in the CKD-MBD model rats by targeting FGF23-Klotho signaling axis

Front Pharmacol. 2024 Jul 23:15:1446609. doi: 10.3389/fphar.2024.1446609. eCollection 2024.

Authors

Bu-Hui Liu^#^{1

2}, Fee-Lan Chong^#³, Can-Can Yuan^#¹, Ying-Lu Liu⁴, Hai-Ming Yang⁴, Wen-Wen Wang¹, Qi-Jun Fang¹, Wei Wu⁴, Mei-Zi Wang¹, Yue Tu⁵, Zi-Yue Wan⁶, Yi-Gang Wan^#⁴, Guo-Wen Wu^#⁷

Affiliations

¹ Department of Traditional Chinese Medicine, Nanjing Drum Tower Hospital Clinical College of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
² Nephrology Division, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
³ The School of Pharmacy, Management and Science University, Shah Alam, Malaysia.
⁴ Department of Traditional Chinese Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China.
⁵ Department of Traditional Chinese Medicine Health Preservation, Acupuncture, Moxibustion and Massage College, Health Preservation and Rehabilitation College, Nanjing University of Chinese Medicine, Nanjing, China.
⁶ Department of Social Work, Meiji Gakuin University, Tokyo, Japan.
⁷ Jilin Province Huinan Chonglong Bio-Pharmacy Co., Ltd., Huinan, China.

^# Contributed equally.

Abstract

[This corrects the article DOI: 10.3389/fphar.2020.586725.].

Keywords: ERK1/2-SGK1-NHERF-1-NaPi-2a pathway; FGF23-klotho signaling axis; chronic kidney disease-mineral and bone disorder; fucoidan; phosphorus reabsorption.

Publication types

Published Erratum